Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gleamer
Saint-Mandé, Francegleamer.ai ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Gleamer’s AI-powered solutions have demonstrated improved sensitivity and specificity in fracture detection across multiple anatomical sites while reducing reading time. Their flagship product "BoneView" has received both CE certification and FDA clearance. The company’s technology has been validated in over eighty clinical studies with more than thirty peer-reviewed publications. Their new product "BreastView" recently received CE-certification for mammography analysis. The company processes over thirty-five million patient exams per year across more than two thousand health institutions worldwide. Recent acquisitions expand their portfolio into MRI diagnostics.
- Therapeutic areas
- PulmonologyOncologyEndocrinologyOtherRheumatologyNeurology
- Modalities
- Device (AI software for medical imaging)Non-pharmacological therapy (clinical decision support)Platform (AI-based diagnostic platform)
- Industry
- Medical Imaging
02
Partnerships
Strategic partnerships with hospitals/institutions globallycollaborations with academic/government clusters such as Jean Z cluster in France
Beyond the preview
Go deeper on Gleamer.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gleamer.